Clinical trial
DART-HN - Daily Adaptive Radiotherapy of Head-neck Cancer.
NCT07506902 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DART-HN - Daily Adaptive Radiotherapy of Head-neck Cancer.
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 21, 2023
- Completion date
- December 31, 2028
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head & neck squamous cell carcinoma